Neuronetics, Inc. (STIM) › Cash & EquivalentsNeuronetics, Inc. (STIM) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2017: $29.15M2018: $104.58M2019: $75.71M2020: $48.96M2021: $94.14M2022: $70.34M2023: $59.68M2024: $18.46M2025: $28.13M$28.13M2017Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$28.13M+52.4%2024$18.46M-69.1%2023$59.68M-15.2%2022$70.34M-25.3%2021$94.14M+92.3%2020$48.96M-35.3%2019$75.71M-27.6%2018$104.58M+258.8%2017$29.15M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share